Commit To Purchase Jounce Therapeutics At $2.50, Earn 17% Annualized Using Options
September 30, 2019 at 11:53 AM EDT
Investors eyeing a purchase of Jounce Therapeutics Inc (JNCE) stock, but cautious about paying the going market price of $3.30/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2020 put at the $2.50 strike, which has a bid at the time of this writing of 20 cents..